Impact of Baricitinib on Patients’ Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry

The efficacy and safety of baricitinib for treatment of atopic dermatitis have been demonstrated in clinical trials; however, very few real-life studies have been published to date. The Observatory of Chronic Inflammatory Skin Diseases (OMCCI) registry was initiated to prospectively determine the lo...

Descripción completa

Detalles Bibliográficos
Autores principales: REGUIAI, Ziad, BECHEREL, Pierre André, PERROT, Jean Luc, FOUGEROUSSE, Anne Claire, BEGON, Edouard, POREAUX, Claire, BOULARD, Claire, CHABY, Guillaume, FITE, Charlotte, ZARAA, Inès, LONS-DANIC, Dominique, LIEGEON, Anne-Laure, PARIER, Josiane, QUILES-TSIMARATOS, Nathalie, DAVID, Laurene, MACCARI, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566517/
https://www.ncbi.nlm.nih.gov/pubmed/37800349
http://dx.doi.org/10.2340/actadv.v103.14153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566517/
https://www.ncbi.nlm.nih.gov/pubmed/37800349
http://dx.doi.org/10.2340/actadv.v103.14153

Ejemplares similares